Chronic Pain and Conditioned Pain Modulation After on Line-behavioral Approach
Be-Home-Pain
Effectiveness of Home- Behavioral Approach by Mindfulness Added to Pharmacological Treatment on Endogenous Pain Modulation in Patients With Chronic Pain: Results at Long-term (Be-Home-Pain)
1 other identifier
interventional
35
0 countries
N/A
Brief Summary
Chronic pain is a disabling condition associated with progressive changes and decline in psychological wellbeing. According with a modern conceptualization, pain has to be considered a biopsychosocial disorder where biological, affective, social and psychological aspects are strictly connected. Although this new conceptualization, the implementation of an integral systems approach of psychological tenets into treatments for chronic pain are limited. Concerning treatments of chronic pain condition, the literature of the last years has demonstrated how clinical benefit can be improved when traditional therapies are combined with behavioral approaches in particular mindfulness. Systemic quantitative-somatosensory testing of Conditioned Pain Modulation (CPM) can be considered a measure of endogenous modulation of pain and it has been used in different clinical experiences to evaluate the effectiveness of different pain treatments even if non pharmacological approaches.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2021
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 31, 2021
CompletedFirst Posted
Study publicly available on registry
April 26, 2021
CompletedStudy Start
First participant enrolled
September 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2022
CompletedJuly 29, 2021
April 1, 2021
8 months
March 31, 2021
July 28, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change of pain intensity
Mean NRS (Numerical Rating Scale evaluation from the Daily diary card ) difference of at least 2 points on the scale(the scale range is from 0=no pain to 10 =maximum pain perceived) between MIND/TAU and TAU groups assessed by the daily diary card.
From the first visit to the first follow up at 3 months till the last follow up at 12 months
Secondary Outcomes (7)
Change of pain frequency
6 and 12 months
Change of medication intake
6 and 12 months
Neurophysiological indexes
3, 6 and 12 months
Psychological measures - coping strategies
6 and 12 months
Psychological measures - Quality of life
6 and 12 months
- +2 more secondary outcomes
Study Arms (2)
Treatment as usual (TAU)
OTHERAny pharmacological therapy used for managing chronic pain or chronic migraine
TAU plus behavioral approach
OTHERAny pharmacological therapy used for managing chronic pain or chronic migraine added with behavioral approach (mindfulness) delivered on line and smart phone for 6 weekly sessions
Interventions
Behavioral approach (mindfulness) delivered on line and smart phone for 6 weekly sessions
Any pharmacological therapy used for managing chronic pain or chronic migraine
Eligibility Criteria
You may qualify if:
- Diagnosis of chronic Migraine and Chronic Neuropathic Pain
- Written informed consent
You may not qualify if:
- Co-existent severe medical or psychiatric illnesses
- Practice of mindfulness in the last 12 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- None (Open Label)
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 31, 2021
First Posted
April 26, 2021
Study Start
September 1, 2021
Primary Completion
May 1, 2022
Study Completion
May 1, 2022
Last Updated
July 29, 2021
Record last verified: 2021-04
Data Sharing
- IPD Sharing
- Will not share